Intranasal trivalent live attenuated influenza vaccine
Record ID 32011001463
English
Authors' objectives:
Live attenuated influenza virus vaccine (LAIV), administered by nasal spray or drops, is an alternative to inactivated influenza virus vaccines, which are generally administered by intramuscular injection. Trivalent, cold-adapted LAIV formulations (CAIV-T), sometimes referred to only as LAIV, are administered annually via intranasal spray in healthy children and adults, to prevent infection with influenza viruses A/H3N2, A/H1N1, and B.
Details
Project Status:
Completed
Year Published:
2011
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=7287
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Influenza Vaccines
- Influenza, Human
- Vaccines, Attenuated
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2011 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.